Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed nutritional strategy.
To regulate growth and avoid catabolite repression, lactose is commonly provided as the initial carbon source because it is metabolized slowly and does not trigger rapid biomass accumulation. Nitrogen availability is kept limited to further restrict vegetative growth and promote secondary metabolism. When lactose becomes depleted, glucose is added at controlled, low rates to prevent repression of penicillin biosynthesis. This sequential feeding strategy helps redirect metabolic flux toward antibiotic production rather than fungal biomass.
Industrial strains such as P. chrysogenum X-1612 have undergone extensive classical strain-improvement programs using UV irradiation, chemical mutagens, and selection for high-yield variants. These strains are capable of producing significantly higher penicillin titers than their natural counterparts. For the production of penicillin G (benzylpenicillin), phenylacetic acid is fed gradually into the fermenter as a side-chain precursor, as excessive concentrations can inhibit fungal growth.
Following fermentation, penicillin is extracted from the broth and converted into 6-aminopenicillanic acid (6-APA), the core molecule used to synthesize a variety of semisynthetic penicillins with improved stability, broader activity spectra, and enhanced pharmacological properties. The culture medium that supports this process typically contains a controlled carbon source, such as lactose or molasses, and a nitrogen source like corn steep liquor, along with minerals and trace elements that promote fungal growth and secondary metabolite formation.
Many antibiotics are naturally produced by microbes.
Penicillin, one of the most widely used antibiotics, is produced by the fungus Penicillium chrysogenum.
For industrial production, high-yield fungal strains are first cultivated in seed cultures and then scaled up in large bioreactors.
The fermentation medium contains lactose as the carbon source, with added nitrogen and sulfur sources.
Glucose is added in minimal quantities to support fungal growth, as higher glucose concentrations can suppress penicillin synthesis, a process known as carbon catabolite repression.
The culture is maintained at 25 to 27 °C and within a pH range of 6.8 to 7.4.
Initially, the fungal cells multiply exponentially, building up the biomass with minimal penicillin production.
As carbon sources become depleted, the culture enters the stationary phase and begins producing penicillin.
At this stage, phenylacetic acid is added as a precursor to direct the synthesis of a specific variant, penicillin G.
After about a week of fermentation, the broth is filtered and purified to collect the penicillin.